Results 1 to 10 of about 30,144 (233)

The impact of patent activity on idiosyncratic volatility in U.S. pharmaceutical companies. [PDF]

PLoS One
Atilgan E, Türkmen Ceylan FB, Doruk ÖT, Ertuğrul HM, Barak AY.   +4 more
europepmc   +1 more source

Global mechanisms to improve affordability of high-priced medicines: the role of the WHO model lists of essential medicines. [PDF]

J Pharm Policy Pract
Jenei K.
europepmc   +1 more source

Impact of combined medication payment management policies on population health performance. [PDF]

PLoS One
Duan D, Yang Y.
europepmc   +1 more source

Emulsion Quality and Functional Properties of Natural Emulsion Systems with Xanthan Gum as a Stabilizer and Carrier of Compounds Based on Enzymatically Modified Mutton Tallow and Hemp Oil. [PDF]

Molecules
Kowalska M, Wozniak M, Zbikowska A, Szakiel J, Turek P.   +4 more
europepmc   +1 more source

Pharmaceutical Patents and Economic Inequality.

Health and human rights, 2023
openaire   +2 more sources

Correction: The unexploited potential of data systems tracking medicines utilization: an opportunity to improve access to oncology combination therapies. [PDF]

Front Pharmacol
Simoens S, Dodwell D, Hartevelt M, Lindgren P, Pistollato M, Pont LG, Pontes C, Roediger A, Sablek A, Van Ganse E, Wang Q, Wenger C, Wilsdon T, Xoxi E, Godman B.   +14 more
europepmc   +1 more source

Impact of Chinese national centralized volume-based drug procurement policy on health costs and utilization: An interrupted time series analysis using panel data (2009-2022). [PDF]

PLoS One
Jiang Y, Wan G, Shi Y, Pu G, Shao X.
europepmc   +1 more source

Horizon scanning and drug expenditure for rare diseases: three-year predictive model in Italy 2025-2027. [PDF]

Health Econ Rev
Marcellusi A, Cazzato D, Guarnotta G, Aiello A, Bonfanti M, Bitonti R, Guardigni M, Lucchetti C, Luccini F, Canonico PL, Jommi C.   +10 more
europepmc   +1 more source

Correction: Investigation of the impact of brewing parameters on toxic element and rare earth element contamination in oolong tea. [PDF]

Front Nutr
Wu S, Peng Z, Ou Y, Mhungu F, Wang Y, Zhang Y, Liu L, Lei J, Huang L, Peng R, Bai Z, Zhang W.   +11 more
europepmc   +1 more source

Cost-effectiveness of hypofractionated radiation therapy versus conventional radiation therapy for unresectable stage III non-small cell lung cancer. [PDF]

Sci Rep
Zhang H, Liu Y, Zeng G, Hu S, Li H, Wang H.   +5 more
europepmc   +1 more source